Unlike the recent global trend of a decline in the prohibition of the use of Cannabis sativa for recreational and medical uses, Barbados and other small island states in the Caribbean have maintained their prohibitive legislation and policies on the use of the herb. A negative social construct of the use of cannabis and its effects in the consciousness of many in the Caribbean have contributed to the maintenance of the prohibitive policies towards the use of the herb. This article highlights the negative societal construct of the herb and its impact on the youth as two critical factors limiting the implementation of medical marijuana laws. It conceptualises a possible policy framework that would address this issue by enabling a phased implementation of the use of medicinal products from marijuana in the management of selected conditions from an evidence-based vantage point. Barbados would need to evaluate the mechanisms under current prohibitive legislation and create amendments to allow for an incremental approach on the use of the plant or products thereof for medicinal purposes in light of societal concerns. The policy framework should result in discreet enforceable mechanisms to facilitate and monitor the importation and development of efficacious and safe medicinal products for prescribing to authorised patients throughout the island's healthcare system.
Introduction
In the Caribbean island of Barbados, the use, sale, possession and cultivation/production of cannabis and its derivatives is illegal. The Barbados Drug Abuse (Prevention And Control) Act Chapter 131 represents the prohibitive stance of the Government of Barbados towards the use, possession, cultivation, sale and trafficking of cannabis in any form. Other territories in the Anglophone Caribbean like Jamaica, Belize and Antigua and Barbuda have decriminalised marijuana while Caribbean Community (CARICOM, 2017) countries 1 have established a regional marijuana commission to investigate the status of marijuana in its member states. This article explores the potential for the small island developing state of Barbados to implement Medical Marijuana Legislation and a framework for the safe and efficacious prescription and administration of cannabinoid products. It examines legalisation in relation to the use of marijuana or its products for medical purposes only. Apart from the laws and restrictions in place in Barbados, the social construct of marijuana in the island as a substance of abuse and of great harm to the young impacts on the perception of its use as a medicine. The cultural constraints and societal constructs in Barbados require careful consideration before any implementation of a policy allowing the use of medical marijuana. The following sections of the article draw comparisons between Barbados and its Caribbean neighbours that have decriminalised marijuana. It explores the suitability of an incrementalist approach to changing the island's drug policy vis-a`-vis marijuana for medical purposes. It reviews grey and published literature on the subject and engages comparisons of policy and actions in other jurisdictions to draw lessons that may be useful in the Barbadian context.
Historical overview of marijuana prohibition and its influence on Barbados' prohibition polices
The use of Cannabis sativa dates to 3000 BC on the continents of Asia and Europe (Nutt, 2012) . In the Western hemisphere, it is commonly referred to as marijuana from its xenophobic association with Mexicans migrating to the United States of America (USA). Marijuana earned its first recognition as a harmful intoxicant in the 1920s and 1930s. During this time, exaggerated accounts of violent crimes allegedly committed by immigrants intoxicated by marijuana became popularised by tabloid newspapers and the newly formed Federal Bureau of Narcotics in the United States of America (National Organisation for the Reform of Marijuana Laws, 2003) . It can be argued that much of this racial prejudice transcends the USA. In the former British colonies in the Caribbean, prior to the proclamation of the Dangerous Drugs Ordinance of 1937, cannabis was the drug of choice of the East Indian population in Guyana, Jamaica and Trinidad and Tobago where it could be purchased in shops (Klein, 2001) . Currently in the USA, 29 states' laws allow for the medical use of marijuana under a physician's supervision.
2 Since the decriminalisation of cannabis in California in 1996, several other states in the USA have followed suit by referendum between 1996 and 2000 (Pacula et al., 2015) . Subsequent to that period, policies facilitating dispensing and patient registration systems have been implemented in response to competing legislative, administrative and judicial actions for cannabis for medical purposes (Pacula et al., 2015) . This was done even with the US federal prohibition of marijuana (National Organisation for the Reform Medical Marijuana Laws, 2003) . However, recent pronouncements by President Donald Trump's administration may facilitate federal prosecutors exercising discretion to bring charges for cannabis (Egger, 2018) .
Global prohibitive polices are evidenced in The United Nations Office on Drugs and Crime Single Convention on Narcotic Drugs 1961 and its Convention on Psychotropic Drugs 1971. These international treaties govern the control of drugs and have informed laws on cannabis use in Barbados and categorise marijuana as Schedule I classifying it as a dangerous drug. Article 4(c) of the Single Convention on Narcotics 1961 under General Obligations states
The parties shall take such legislative and administrative measures as may be necessary . . . subject to the provisions of this Convention, to limit exclusively to medical and scientific purposes the production, manufacture, export, import, distribution of, trade in, use and possession of drugs.
The Laws of Barbados refer to cannabis as 'any plant of the genus Cannabis from which the resin has not been separated and includes any part of that plant by whatever name it may be designated' (Drug Abuse (Prevention And Control) Act Chapter 131). Sections 4-9 and 11 of the Act make C. sativa cultivation, possession, import, export, sale/supply, misuse and possession of any equipment for its use as well as its resin illegal in the island. Furthermore, the possession of cannabis on or near 3 school premises, the inclusion of a child or young person in the drug trade and the purchase of cannabis from a child or young person is illegal and on indictment could result in imprisonment for life (Drug Abuse (Prevention and Control) Act Chapter 131). More so, there has also been debate in Barbados about the power of the Minister of Health under Section 12 of Barbados' Drug Abuse (Prevention and Control) Act Cap 131 to grant permission for medical use upon prescription of marijuana with one attorney requesting such permissions (Bradshaw, 2016) . While provisions seem to be in place for the access of the herb or derivatives of the plant for medicinal purposes under the aforementioned legislation, there is reluctance to allow such use.
Social construction of Marijuana: Its impact on implementing medical marijuana laws in Barbados
Part of the Anglophone Caribbean, Barbados is a small island state with a population of approximately 270,000 occupying 166 square miles. Unlike other Caribbean territories, it was only colonised by Britain. Chamberlain (2010) characterises 1930's colonial Barbados as being the most politically conservative island and while racially divided it did not possess political and racial tensions like neighbouring Jamaica, Trinidad and Guyana with their East Indian populations. Furthermore, its transition to an independent nation state was seamless with violence not being part of the culture (Chamberlain, 2010) . The 2010 Barbados Census indicates that 96.8% of those expressing religious affiliation are Christian (Barbados Statistical Service, 2013) . The non-Christians include Muslims, Jews, Hindus, Rastafarians 4 and Baha'i faith members (Barbados Statistical Service, 2013) . Rastafarianism was introduced to Barbados in 1975. It originated in Jamaica in the 1920s and was thought to attract 'undesirable elements, such as criminals and rebellious youths who used it as an excuse to smoke marijuana', making it unfavourable for 'conservative Barbadians' (Elias, 2000: 79) . As mentioned earlier cannabis use in the Caribbean had greater association with East Indian populations, which did not feature prominently in Barbados. The social construction and acceptance of cannabis as part of the East Indian culture in Jamaica sees its legislation using the term 'ganja' instead of cannabis or marijuana. Additionally, the association of marijuana with rebellious Rastafari came into conflict with Barbadian culture and conservatism. These associations present a challenge to changing the societal perception of marijuana as a substance of abuse and social ill to a medicine and, given its conservative nature represents a radical reform.
A social construct is a concept or perception developed and maintained by society based on their collective views. It can be argued that the distinction made between marijuana as a 'medicine' or a 'drug' is one that is socially constructed and culturally bound in Barbados (Griffith and Cohall, 2017) . Generally, legal and medically sanctioned substances are set apart from those substances that are met with social disapproval. That is, medicines are accepted given their regulation and recommendation by medical personnel while drugs, synthetic or natural, are viewed as harmful to society especially the youth. The science of the medicinal effects of the plant and its bioactive constituents, primarily the cannabinoids which act on cannabinoid receptors (CB 1 and CB 2 ) in the central nervous system and other tissues is well established (Mechoulam, 1986; Pacher et al., 2006) . These receptors are usually activated by the endogenous cannabinoid or endocannabinoid, Anandamide. The endocannabinoid system controls appetite, pain sensation, mood, pleasure sensation, immune system and memory (Pacher et al., 2006) .
The acceptance of marijuana as a drug or medicine by Caribbean society resonates on the perception of the herb, with a negative connotation persisting in an era when the science of its medicinal benefits is known (Griffith and Cohall, 2017) . In the context of Barbados, results from a nationally representative survey in 2014 showed that majority of Barbadians (59%) believed that marijuana was harmful and only 36% of the population thought it was beneficial for one's health (Wickham, 2016) . Barbadians did not view the herb as a 'medicine' or possessing health benefits then, although, only 37% of the population supported its continued prohibition (Wickham, 2016) . In June 2017, a more recent CADRES poll demonstrated a change in the attitude and views of Barbadians towards its marijuana laws as 52% of the population now support either decriminalisation or full legalisation (Smith, 2017) . This shows a shift in the views of the population which may be due to increased education about the efficacy of the forms of treatment and current global trends in the implementation of medical marijuana laws elsewhere. Upon examining youth perceptions of harm in the National Council on Substance Abuse (NCSA) Barbados Secondary School Surveys, it is seen that more of the students aged 11-18 years perceive marijuana as very harmful compared with those who did not see it as harmful in both 2006 (42.7%) and 2013 (31.4%). More specifically, the frequency of use impacted on the perception of harm with frequent use being perceived as very harmful by majority of the youth in both years (70.2% in 2006 and 61.0% in 2013) . A reduction in the perception of harm among the youth was observed upon comparing the two years. The most recent data from the year 2013 on youth use of marijuana based on the current prevalence rate are 11%, increasing from 6% in 2006.
Interestingly, the Jamaican Minister of Health, Dr Christopher Tufton informed Jamaican Parliament on 28 June 2016 that subsequent to the relaxed marijuana laws in that country that adolescents seeking treatment for cannabis-related adverse effects through the country's National Council on Drug Abuse (NCDA) treatment programme had increased by 50% (Jamaica Observer, 2016). It appeared that the revised laws in Jamaica may have spiked an increase of use of the plant, which may have supported the views of less liberal Barbadians on the issue. However, the Deputy Chair of Jamaica's NCDA Professor Wendel Abel has refuted such claims. He posited that the data in the report by the NCDA had been misinterpreted and, furthermore there was no evidence to suggest that any change in use of the plant since decriminalisation as it had been stable post the relaxation of the laws (Jamaica Observer, 2017).
Marijuana policy reform efforts in CARICOM
Initially, all member states of CARICOM had prohibitive laws and policies against the use of cannabis in any form and for any purpose. Of these CARICOM countries, Jamaica was the first to amend its Dangerous Drugs Act in 2015 and decriminalise cannabis to make the possession of up to two ounces or 56 grams a minor offence. In the context of Jamaica, it was thought that the criminalisation of cannabis was akin to the criminalisation of cultural practice in a country where the state agencies' perspective of it as a drug clashed with its cultural perception (Chevannes, 2004) . Subsection 3(a) of Section 7D of the Jamaica Dangerous Drugs (Amendment) Act also created the legal environment to cultivate ganja for scientific and medical research (Dangerous Drugs Act, 2015) . Section 6(2) makes provision for those who have been prescribed marijuana by a registered medical practitioner or health practitioner as approved by the Ministry of Health as published in the Gazette. It could be argued that Jamaica's cultural awareness and historical use of C. sativa by its Rastafarian community and the populace may have accelerated legal reform on the use of the herb in the country, after its establishment of its Ganja Commission in 2000. There have also been pronouncements about the economic arguments supporting the possible pharmaceutical trade and a reduction in the state's financial burden to incarcerate young men who were prosecuted for small quantities of the herb (Davenport and Pardo, 2016) CARICOM (2017) has embraced marijuana policy reform and has established its Regional Commission on Marijuana that is presently investigating whether the prohibitions on the drug should be removed for religious, research, recreational and/or medicinal use. The issues surrounding marijuana decriminalisation and legalisation of as they have occurred in the Caribbean thus far have addressed issues of social justice and in some cases medicine simultaneously. This article restricts its analysis to legalisation of cannabis for its medical use and possession under specific amounts and for specific conditions, in other words the legal medical authorisation to use and possess the herb. As mentioned earlier, this differs from its full legalisation where existing laws would be repealed and the herb could be cultivated, possessed, sold and bought by anyone with certain restrictions or regulations like alcohol and tobacco.
Implementation of medical marijuana laws in Barbados: Possible approaches?
The incrementalist model of policymaking acknowledges that attempting rational approaches result in consumption of time and in reality, government decisions are made in small steps (Mayer, 1985) . It is posited that marginal adjustments to existing policy ensure that a faster response can be made to unanticipated consequences with there being greater ease for securing agreement on small changes although being a conservative approach to change (Walker, 1984) . It is this reason that the gradual approach towards implementing medical marijuana laws is favoured for Barbados. Marginal adjustments to existing policy can be done in at least two phases. Phase one could see the addition of approved marijuana derived medicines to the drug formulary while phase two would see the introduction of different formulations of raw forms, tinctures and oils that have shown bioequivalence to established forms of medical cannabis products. These phases will be described in the subsequent section.
The island has established a reputation for itself as having high healthcare standards. There is a universal healthcare system established by the 1969 Health Services Act of Barbados and the Drug Service Act in 1980. Its regulation of medical practitioners and allied services serves as a good foundation for the regulation of prescribed medical marijuana in very much the same way as other medicines considered as controlled substances. The Medical Council has the authority under the Medical Profession Act, 2010 to register medical practitioners, regulate standards of medical practice in the public interest, establish and maintain a system for standards in training and competency of medical practitioners, investigate the professional conduct and performance or ability of registered medical practitioners and most importantly, to sanction such professionals under a Code of Practice (Section 3[4]). In California, the Medical Board of California (MBC) fulfils a similar function and the state law protects doctors who recommend medical marijuana 5 from punishment. The MBC can discipline those who do prescribe medical marijuana but fail to comply with acceptable medical standards (Department of Justice, State of California, 2008). Similar disciplinary and protective measures can be implemented in Barbados under the jurisdiction of the Medical Council of Barbados. The present restriction on doctor's advertisement of services could restrict the potential for physicians to advertise medical marijuana services as a safeguard measure.
Protection of the adolescent population from the illegal and excessive non-medical use of the herb could be established by increasing the scope of Barbados' Health Services Amendment Act 2009, which specifically prohibits the use of tobacco by minors and their exposure to its smoke. In Belize, young persons under the age of 18 years found in possession of marijuana will be required to participate in a Minister approved drug treatment or drug counselling programme (Misuse of Drugs (Amendment) Act, 2017). Likewise in Antigua and Barbuda, the Misuse of Drugs (Amendment) Act, 2018 Section 6 C also clearly indicates that a person under the age of 18 years found in possession of cannabis or its resin will be required to participate in a Minister approved drug counselling programme. It also makes the use of cannabis at a school an offence. Similar recommendations can be implemented in Barbados but ensure adults 18þ years in breach of the law are prosecuted accordingly. In Belize, the amendment allows for possession on the premises of educational institutions to be treated on the first occasion with a warning and on a subsequent occasion, possibly a ticketed fine (Belize Misuse of Drugs (Amendment) Act 2017 Section 7 [b] [i]). In Barbados, the law could be amended to outline mechanisms to safeguard the access of medical marijuana to minors inclusive of best practices for its dispensing and administration to minors and their environs as well as strengthening rehabilitation programmes for the young. The previously cited Drug Abuse (Prevention And Control) Act Chapter 131 of Barbados has protections for youth but given the prohibitionist policy in place, restrictions are not limited to smoking and may be too restrictive for medical marijuana laws. It serves as a good reference for how minors may be protected in a context where marijuana has been legalised for medical purposes. California has similar prohibitive policies to protect youth under their 'Guidelines for the Security and Non-Diversion of Marijuana Grown for Medical Use' (Department of Justice, State of California, 2008). More so, the Enforcement Section of the Californian Guidelines stipulate that medical marijuana may not be smoked 'at or within 1000 feet of a school, recreation center, or youth center (unless the medical use occurs within a residence) [or] on a school bus' (Department of Justice, State of California, 2008) .
In essence, there are four basic dimensions of medical marijuana regulation that have been identified by Lynne-Landsman et al. (2013) that could supplement an incremental approach towards policy reform on the use of medical marijuana in Barbados. There should be a registry and means of identifying those persons who are legitimately prescribing and prescribed marijuana. Guidelines must be established for medical professionals detailing the conditions for which marijuana can be prescribed similar to other controlled substances. In addition to regulations for cultivation, possession, dispensing and sale of medical marijuana, there also needs to be protection for the patient from prosecution (Lynne-Landsman et al., 2013) . These regulations will allow only those with prescriptions to access and possess medical marijuana. They will also assist in safeguarding the trade from cultivation to dispensaries and reduce access to the drug, especially by adolescents, unless it has been prescribed.
Phased access to Medical Marijuana in Barbados
Barbados can use the framework described above to facilitate access to medical marijuana products in at least two phases. More specifically, the island can facilitate access to medical marijuana through its pharmaceutical aid scheme and other provisions under the 1980 Drug Service Act of Barbados. Phase one of the process will allow approved medical marijuana products to be added to the national formulary and be accessible under universal healthcare or at full cost to the patient. Medical marijuana products that are United States Food and Drug Administration (USFDA) approved or approved by any other equivalent drug regulatory body, as safe and efficacious should be considered for access among Barbadians to treat conditions where the evidence supports their use. A recent meta-analysis has outlined that various formulations of medical marijuana can be administered for the management of various conditions (Whiting et al., 2015) . Some of the more popular formulations include parenteral and enteral forms and tinctures. Nabilone (synthetic cannabinoid mimicking THC) was approved by the USFDA in 1985 and marketed in the United Kingdom, Mexico and Austria as an orally administered drug for pain, nausea and vomiting. Dronabinol, also a synthetic THC, is licensed primarily in the US and Germany for similar indications as Nabilone and also for appetite stimulation in HIV patients. Nabiximols (27 mg THC:25 mgCBD/ml) is formulated in an oromucosal spray and is licensed for use in Europe and Canada for spasticity due to multiple sclerosis. Findings in the meta-analysis have shown moderate quality evidence for the use of cannabinoid product(s) for spasticity and for the improvement in pain while in some cases, there has been low-quality evidence for appetite stimulation in HIV patients, and nausea and vomiting due to cancer chemotherapy (Whiting et al., 2015) . These potential products can be considered in the first phase of approved medical marijuana products in Barbados. This phased approach will gradually lead to the implementation of a controlled list of cannabinoid products for use within the local healthcare system. New medicinal products will be required to satisfy the established criteria of the National Drug's Formulary Committee under the Drug Service Act of Barbados before they can be accepted for use. This may include further quality and specification testing of any product made or imported by a reputable entity before comprehensive approval for use. It is phase two and beyond where medical marijuana legislation would be implemented to safeguard patients from further prosecution and abuse of cannabis-related products, provide further protection of the youth and to regulate a supply chain from cultivation to dispensaries.
Research by Davenport and Pardo (2016) draws attention to the need for age restrictions for medical use, regulations on third-party possession, possible restrictions on advertising and of specific relevance to Barbados, the criteria for permission to import or to cultivate and produce marijuana products. The cultivation, production, supply and dispensing of these medical products should also be considered within the local context to ensure continued supply of the medicine to patients who may benefit from cannabinoid products. Medical cannabis products in this phase will be imported primarily as in the case of products in phase one but could be in raw forms, tinctures and oils that have satisfied bioequivalence specifications of established efficacious and safe medical cannabis products. A supply chain must be in place to safeguard the right of access of the products to patients, which must also be tightly regulated (Lynne-Landsman et al., 2013) . It is anticipated that private, public or university enterprises should be able to facilitate and monitor a supply chain through research and product development under the provisions of medical marijuana laws. Within the supply chain, there should be specifications of storage practices to ensure that the medical marijuana products conform to the same standards used for other controlled medicines. Regulations should also adjudicate quality assurance requirements. These quality assurance requirements may include testing for product specifications on the bioactive ingredients, moulds, pesticides and other contaminants along with directions for storage. A possible and distinct phase three to the implementation of medical marijuana laws in Barbados could consider the local cultivation of medical-grade cannabis at an industrial level.
Potential challenges to the implementation of medical marijuana laws in Barbados
Jamaica is said to resemble a hybrid model that allows for growth of plants and purchase from licensed stores/ pharmacies (Davenport and Pardo, 2016) . In Jamaica, the allowance of up to five plants for personal use enables 'self-medication' and creates potential challenges to having people pursue legal channels to obtain medical marijuana where dosages can be better monitored.
6 There may also be challenges to implementing medical marijuana from black market sources if these prove cheaper and more accessible. It is felt that continued illegal cultivation of marijuana prohibits successful implementation of a medical marijuana scheme (Jones et al., 2017) . Jones et al. (2017) make the point that there are several potential threats to the successful implementation of medical marijuana in Jamaica including the cost of registration, an extremely restrictive list of medical conditions, misaligned forms of medical marijuana based on demand and an overly complicated registration process. Given the present concerns in Canada where their demand is fast outstripping supply (Zochodne, 2017) , another consideration in the case of a small developing country like Barbados would be the ability of official entities to provide the volume of marijuana that may be required to satisfy the demand.
The safety profile of cannabinoid-related products and also the lack of its understanding have significantly upheld the debate on the necessity for prohibitive polices in some jurisdictions, especially in Barbados. Several comparisons have been made between marijuana and alcohol in relation to their toxic effects, given that an excess of alcohol can be fatal and it is no longer bound by prohibitive polices. It has also been touted that the harms associated with smoking marijuana are similar to the smoking of tobacco (lung damage), which too is not prohibited. The likelihood for accidents or injury while intoxicated, the impairment of judgement while intoxicated and the link of marijuana to depression and psychosis have also been noted (Nutt, 2012) . Cannabis dependence is said to occur in 10% of users and is also associated with unpleasant withdrawal symptoms (Nutt, 2012) . More so, the abuse of the herb has shown short-and longterm effects on cognitive function and brain development (Volkow et al., 2014) . More specifically on the cannabis-related substances, meta-analysis data with cannabinoid substances have highlighted the unlikely death from the administration of cannabinoid substances with odds ratio (95% CI) 1.01 (0.51-2.00). Dizziness, euphoria, hallucination and psychiatric disorders were also noted from studies that assessed the adverse effect profile of cannabinoid products in recent trials, mainly the THC-related products. Psychiatric disorders have been shown to be present in persons predisposed to psychosis and had a summarised estimate of odds ratio (95% CI) 3.10 (1.81-5.29) (Whiting et al., 2015) .
Limitations
This article did not address the issue of local cultivation of medical marijuana in any detail whether at a personal or on a national level. It is evident that Jamaica has gone the route of allowing personal cultivation of up to five plants although there are no specifications of heights or CBD or THC content (Laws of Jamaica). Likewise, Antigua and Barbuda's Misuse of Drugs (Amendment) Act, 2018 allows for the personal growth of up to four plants without specifying heights or CBD or THC content (Laws of Antigua and Barbuda). Once the production of cannabis is controlled by a government agency, signatories to the Single Convention on Narcotic Drugs 1961 are allowed to produce cannabis for medical purposes. However, cultivation of medical-grade cannabis at an industrial level requires an analysis that was not the intention of this paper. Similarly this article only explored a possible phased approach in the introduction of medical marijuana in Barbados, which covered already established products. While the potential for local cultivation of medical-grade cannabis and research into the seized locally grown and imported cannabis are recognised as important steps going forward, this article did not seek to explore this avenue as a concurrent segment to the phased approach described above.
Conclusion
The case for the implementation of medical marijuana laws and policies in Barbados has been outlined above with possible mechanisms to initiate the needed policy framework to implement the use of approved medicinal components of the plant. It was noted that the current prohibitive policies against the use of the plant attempt to protect adolescents and the wellbeing of society. It has been shown elsewhere that the careful implementation of medical marijuana laws and polices does not significantly impact on the use of the herb by the youth. The NCSA or other public health agencies should consider these findings on the impact of the introduction of medical marijuana on the youth's perceptions of plant in their campaign and advocacy. It is thought that legalisation of marijuana for medicinal purposes could foster this delinked environment where access to the known and medicinally tested cannabinoid compounds will be facilitated under a regulated framework. An incremental approach to medical marijuana may work in the context of Barbados where a more modest approach to drug reform is pursued in comparison to its regional counterparts.
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